New Haven Pharmaceuticals company logo

New Haven Pharmaceuticals

newhavenpharma.com

Total Raised

$27.29M

Investors Count

6

Deal Terms

2

Funding, Valuation & Revenue

6 Fundings

New Haven Pharmaceuticals has raised $27.29M over 6 rounds.

New Haven Pharmaceuticals's latest funding round was a Dead for on October 31, 2016.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

10/31/2016

Dead

Dead

$XXM

0

FY undefined

1

8/17/2016

Debt - II

$XXM

$XXM

0

FY undefined

10

10/7/2015

Debt

$XXM

$XXM

0

FY undefined

10

10/23/2014

Series B

$XXM

$XXM

0

FY undefined

10

4/25/2013

Line of Credit

$XXM

$XXM

0

FY undefined

10

Date

10/31/2016

8/17/2016

10/7/2015

10/23/2014

4/25/2013

Round

Dead

Debt - II

Debt

Series B

Line of Credit

Amount

$XXM

$XXM

$XXM

$XXM

Investors

Dead

Valuation

$XXM

$XXM

$XXM

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

1

10

10

10

10

Start free trial
New call-to-action

New Haven Pharmaceuticals Deal Terms

2 Deal Terms

New Haven Pharmaceuticals's deal structure is available for 2 funding rounds, including their Series B from October 23, 2014.

Round

Series B

Series A

Funding Date

$XXM

$XXM

Pre-Money Valuation

$XXM

Post-Money Valuation

$XXM

Amount Raised

$XXM

$XXM

Shares Authorized

Issuance Price

$XXM

Dividend Rate

$XXM

Liquidation Preferences

$XXM

Liquidation Price

Participation

Conversion Price

Anti Dilution

$XXM

General Voting

$XXM

$XXM

Board Voting

$XXM

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

Series A

$XXM

$XXM

$XXM

$XXM

New Haven Pharmaceuticals Investors

6 Investors

New Haven Pharmaceuticals has 6 investors. Horizon Technology Finance invested in New Haven Pharmaceuticals's Debt funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

4/25/2013

10/7/2015

Horizon Technology Finance
2
Line of Credit, Debt (2015)

Debt & Specialty Finance

Connecticut

00/00/0000

00/00/0000

Connecticut Innovations

Subscribe to see more

Venture Capital

Connecticut

00/00/0000

00/00/0000

Yale University

Subscribe to see more

Academic/University

Connecticut

00/00/0000

00/00/0000

EJ Funds

Subscribe to see more

Venture Capital

Connecticut

00/00/0000

00/00/0000

Kuzari Group

Subscribe to see more

Private Equity

New York

First funding

4/25/2013

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

10/7/2015

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Horizon Technology Finance

Connecticut Innovations

Yale University

EJ Funds

Kuzari Group

Rounds

2
Line of Credit, Debt (2015)

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Debt & Specialty Finance

Venture Capital

Academic/University

Venture Capital

Private Equity

Location

Connecticut

Connecticut

Connecticut

Connecticut

New York

New call-to-action

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.